Subscribe to our press releases
ChromoGenics is increasing production capacity to meet demand
ChromoGenics has in six months doubled the capacity in the production facility in Uppsala to meet the increased demand while the cost has been reduced. Last week a new all-time high was reached in production
During 2018 several investments in production equipment and production methods were implemented to secure quality and capacity. Due to the increased demand ChromoGenics has increased the production personnel from five to twelve operators and is planning to recruit even four more. There are also plans to add another shift.
“Our investments have been necessary to secure a quality of highest class and prepare for the increased demand in the market. We have now grounded for a capacity of over 10.000 sqm during 2019 and it is more than a doubling compared to six months ago” says COO Micael Hamberg.
The factory in Uppsala is running at full steam and the increased volume is also affecting the cost structure as the fixed costs will be distributed over larger volume.
“We are clearly noticing the higher demand in our products. In week 6 we did produce above our targets and for two days we set a new all-time high”, says Production Manager Niklas Lundberg.
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail: firstname.lastname@example.org, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.